The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I study of neoadjuvant cisplatin (C), docetaxel (D) and nintedanib (N) for resectable non-small cell lung cancer (NSCLC).
 
Tina Cascone
Honoraria - Society for Immunotherapy of Cancer
 
Boris Sepesi
No Relationships to Disclose
 
Heather Y. Lin
No Relationships to Disclose
 
Neda Kalhor
No Relationships to Disclose
 
Jianjun Zhang
Honoraria - Roche; Sino-USA Biomedical Platform
Consulting or Advisory Role - AstraZeneca
 
Frank V. Fossella
No Relationships to Disclose
 
Anne S. Tsao
Consulting or Advisory Role - ARIAD; Astellas Pharma; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; EMD Serono; Epizyme; Genentech/Roche; Imedex; Lilly; MedImmune; Novartis
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); MedImmune (Inst); Merck (Inst); Millennium; Polaris; Seagen
 
Vincent K. Lam
No Relationships to Disclose
 
Charles Lu
No Relationships to Disclose
 
Frank Mott
No Relationships to Disclose
 
George R. Simon
Honoraria - AstraZeneca; Celgene
Consulting or Advisory Role - ARIAD; Boehringer Ingelheim; Celgene; Genentech/Roche; Lilly; Merck Serono
Speakers' Bureau - AstraZeneca; Celgene
Research Funding - Merck Sharp & Dohme
Travel, Accommodations, Expenses - ARIAD; Celgene; Genentech/Roche; Lilly; Merck Serono
 
Mara Antonoff
No Relationships to Disclose
 
Reza J. Mehran
No Relationships to Disclose
 
David C. Rice
No Relationships to Disclose
 
Ara A. Vaporciyan
No Relationships to Disclose
 
Myrna Godoy
No Relationships to Disclose
 
J. Jack Lee
No Relationships to Disclose
 
Stephen Swisher
No Relationships to Disclose
 
William Nassib William
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; Roche/Genentech
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - Boehringer Ingelheim
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); OSI Pharmaceuticals (Inst)
 
John Heymach
Stock and Other Ownership Interests - Bio-Tree; Cardinal Spine
Consulting or Advisory Role - Abbvie; ARIAD; AstraZeneca; AstraZeneca; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Calithera Biosciences; Genentech; Medivation; Novartis; Oncomed; Synta
Research Funding - AstraZeneca (Inst)